Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
-1.23%
SPX
-1.60%
IXIC
-2.24%
FTSE
-0.70%
N225
-0.66%
AXJO
-0.92%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Overview

Loading chart...

Key Stats

Market Cap
25.06M
Dividend Yield
0.00%
P/E Ratio
-26.83
EPS
-0.03
Revenue
-
Avg. Volume
1.15M

Recently from Cashu

publisher logo
Cashu

ProMIS Neurosciences: Pivotal Mining Note Revolutionizes Cryptocurrency Investment Landscape

2 days ago
publisher logo
Cashu

ProMIS Neurosciences: Pioneering Innovative Treatments for Alzheimer's and Neurodegenerative Disorders

4 days ago

About

What does PMN do?
ProMIS Neurosciences, based in Toronto, develops precision medicine for neurodegenerative diseases, focusing on antibody therapeutics targeting misfolded proteins. The company went public on April 3, 2017, and employs six full-time staff.
Sector
💻 Health Care
IPO
CEO
Employees
7 employees
Headquarters
Ontario, Canada
Website
https://www.promisneurosciences.com
Stocks
Health Care
pmn
ProMIS Neurosciences
NASDAQ: PMN
0.00 (+0.52%)
0.7751
USD
At close at Aug 01, 20:43 UTC
Summary
News
Signals
Benchmarks
Financials